$5.34
+0.03 (+0.57%)
Open$5.32
Previous Close$5.31
Day High$5.41
Day Low$5.21
52W High$33.68
52W Low$5.24
Volume—
Avg Volume668.1K
Market Cap290.83M
P/E Ratio—
EPS$-2.89
SectorBiotechnology
Analyst Ratings
Strong Buy
13 analysts
Price Target
+362.2% upside
Current
$5.34
$5.34
Target
$24.68
$24.68
$18.50
$24.68 avg
$35.72
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.89M | 2.17M | 177.59M |
| Net Income | -145,068,534 | -98,137,162 | -3,219,143 |
| Profit Margin | -5,026.0% | -4,774.7% | -1.8% |
| EBITDA | -161,990,292 | -115,672,562 | -5,179,349 |
| Free Cash Flow | — | — | -3,332,995 |
| Rev Growth | +33.0% | +33.0% | -5.8% |
| Debt/Equity | — | — | 0.62 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $264.48 | +0.20% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $393.16 | +1.95% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $150.56 | +0.30% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $510.72 | +0.47% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $798.17 | +1.70% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $244.32 | +1.99% | 40.0 | 32.33B |